title: Significant and Meaningful Improvement in Treatment Satisfaction with Teriflunomide Versus Subcutaneous IFNB-1A in Patients with Relapsing MS Results from Tenere.
authors.affiliation: Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Mäurer
authors.affiliation: Hasselt University, Diepenbeek, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Van Wijmeersch
authors.affiliation: Strasbourg University, Strasbourg, France.
authors.forename: J
authors.initials: J
authors.lastname: de Seze
authors.affiliation: Universidad Católica San Antonio de Murcia, Murcia, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Meca-Lallana
authors.affiliation: Sanofi, Chilly-Mazarin, France.
authors.forename: S
authors.initials: S
authors.lastname: Bozzi
authors.affiliation: University of Lille Nord de France, Lille, France.
authors.forename: P
authors.initials: P
authors.lastname: Vermersch